Lao Feng Xiang's AI Glasses Debut at Shanghai Senior Expo, Highlighting China's ODM Capabilities in Smart Eyewear for Global Aging Market

Introduction

On March 24, 2026, Lao Feng Xiang's AI glasses, first launched in June 2025, were prominently showcased at the Shanghai Senior Expo. The product integrates voice navigation, real-time translation, and medication label recognition, targeting elderly users' mobility, communication, and health information needs. This development is significant for the smart eyewear manufacturing, elderly care technology, and international trade sectors, as it demonstrates China's growing capability in mid-range smart glasses ODM with medical-assistive functions, potentially disrupting higher-cost European and American solutions.

Event Overview

The AI glasses, developed entirely by domestic supply chains, feature optical modules, voice algorithm integration, and age-friendly industrial design. During the expo, the product attracted inquiries from elderly tech distributors in Japan and Germany. This marks a notable step in China's ability to deliver medically assistive smart glasses at a competitive price point.

Impact on Specific Industries

Smart Eyewear Manufacturing

The successful integration of medical-grade functions in a mid-range product signals China's advancing position in smart glasses ODM. Manufacturers should note the growing demand for cost-effective solutions with healthcare applications.

Elderly Care Technology

The product's focus on practical elderly needs (navigation, translation, medication) sets a benchmark for functional design in aging tech. Providers should observe how these features perform in real-world adoption.

International Trade

The interest from Japanese and German distributors indicates shifting dynamics in global elderly tech sourcing. Trade professionals should monitor how Chinese ODM capabilities may reshape supply chains traditionally dominated by Western manufacturers.

Key Focus Areas and Recommendations

Monitor Technology Transfer Potential

The domestic supply chain's ability to deliver medical-assistive functions suggests potential for technology licensing or joint ventures. Companies could explore partnerships with Chinese optical and voice algorithm specialists.

Evaluate Market Segmentation

Rather than competing directly with premium Western brands, consider how mid-range products with specific elderly-focused features could carve out new market niches.

Assess Regulatory Pathways

As medical-assistive features become more common in consumer wearables, regulatory classifications may evolve. Stay informed about certification processes in target markets.

Observe Adoption Patterns

Track how elderly users in different markets respond to voice navigation versus visual interfaces, as this may inform future product localization strategies.

Editor's Observations

From an industry perspective, this development appears more significant as a capability demonstration than an immediate market shift. The real test will be whether the technology can scale while maintaining medical-grade reliability at competitive costs. What makes this noteworthy is the convergence of several trends: China's optical manufacturing expertise, AI voice algorithm development, and targeted elderly tech design - all areas where incremental improvements could collectively reshape market expectations.

Conclusion

Lao Feng Xiang's AI glasses showcase represents a meaningful step in China's smart eyewear ODM capabilities, particularly for aging population applications. While not yet a market transformation, it signals growing competitiveness in functional, mid-range elderly tech solutions. Industry participants would be prudent to monitor how these capabilities develop, particularly in balancing cost, functionality and medical reliability - a combination that could potentially redefine value propositions in global elderly tech markets.

Source Information

Primary source: Product exhibition at Shanghai Senior Expo, March 24, 2026. Additional context from initial product launch announcement (June 2025). Ongoing monitoring recommended for international distributor adoption rates and manufacturing scalability.